- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Climacteric symptoms after natural or surgical menopause
- Meeting Date: July 2024
- Public Summary Document (PSD) July 2024 PBAC Meeting - (PDF 399KB)
- Public Summary Document (PSD) July 2024 PBAC Meeting - (Word 71KB)
Estradiol – July 2024
Estradiol; Transdermal gel 500 micrograms (as hemihydrate) in 0.5 g sachet; Sandrena®
Last updated
30 May 2025